Notably, the significant enrichment of galectins in antigen processing and presentation pathways, phagosome formation, and the negative regulation of CD4-positive T cell proliferation implicates galectins as central modulators of the tumour–immune microenvironment. The gene discussed is CD4; the disease is neoplasm.